Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rThrombin spray for hemostasis in skin grafting
NCT00371215Phase 2Completed
- Sponsor
- ZymoGenetics
- Start
- Aug 2006
- Primary completion
- Jun 2007
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of thrombin alfa in surgical hemostasis, sponsored by ZymoGenetics. Primary endpoint: Incidence and severity of adverse events at 29 days. Started Aug 2006; status: completed.
02
Drugs
thrombin alfa
03
Conditions
surgical hemostasis
Beyond the preview
Go deeper on NCT00371215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00371215.